Literature DB >> 8071912

Psychiatric morbidity in adults with hypopituitarism.

S Lynch1, S Merson, S A Beshyah, E Skinner, P Sharp, R G Priest, D G Johnston.   

Abstract

Forty-one adults with established hypopituitarism and deficiency of growth hormone (GHD) were compared to an age and sex-matched group with another chronic metabolic disorder (diabetes mellitus) using standardized psychiatric rating and diagnostic measures. Nineteen (46%) of the GHD group were identified as definite psychiatric cases compared with 10 (24%) of the diabetics (odds ratio 1:9:1). The most frequent DSM III-R axis I psychiatric diagnoses were major depression (32% GHD patients and 10% of diabetic patients) and dysthymia. The risk of being a psychiatric case showed an association with duration of illness in the diabetic group, but not in the GHD group. Biochemical indices were not related to the risk of being a case in either group. Hypopituitarism is associated with a higher prevalence of psychiatric disturbance than can be attributed solely to the presence of a chronic disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071912      PMCID: PMC1294682          DOI: 10.1177/014107689408700805

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  14 in total

Review 1.  Alpha 2-adrenoceptors in depression.

Authors:  C L Katona; A E Theodorou; R W Horton
Journal:  Psychiatr Dev       Date:  1987

2.  Attenuated growth hormone response to growth hormone-releasing hormone in major depressive disorder.

Authors:  K P Lesch; G Laux; A Erb; H Pfüller; H Beckmann
Journal:  Biol Psychiatry       Date:  1987-12       Impact factor: 13.382

3.  The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale.

Authors:  P Tyrer; R T Owen; D V Cicchetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

4.  Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency.

Authors:  G A McGauley; R C Cuneo; F Salomon; P H Sönksen
Journal:  Horm Res       Date:  1990

5.  Treatment of craniopharyngiomas--the stereotactic approach in a ten to twenty-three years' perspective. II. Psychosocial situation and pituitary function.

Authors:  M Sääf; M Thorén; C G Bergstrand; G Norén; T Rähn; L Tallstedt; E O Backlund
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

6.  Responses of growth hormone to desipramine in endogenous and non-endogenous depression.

Authors:  T G Dinan; S Barry
Journal:  Br J Psychiatry       Date:  1990-05       Impact factor: 9.319

7.  The educational, vocational, and marital status of growth hormone-deficient adults treated with growth hormone during childhood.

Authors:  H J Dean; T L McTaggart; D G Fish; H G Friesen
Journal:  Am J Dis Child       Date:  1985-11

8.  Growth hormone response to clonidine after recovery in patients with endogenous depression.

Authors:  P B Mitchell; J A Bearn; T H Corn; S A Checkley
Journal:  Br J Psychiatry       Date:  1988-01       Impact factor: 9.319

9.  Recurrent depression is associated with a persistent reduction in sleep-related growth hormone secretion.

Authors:  D B Jarrett; J M Miewald; D J Kupfer
Journal:  Arch Gen Psychiatry       Date:  1990-02

10.  Psychiatric morbidity and social problems in patients with insulin-dependent diabetes mellitus.

Authors:  G Wilkinson; D Q Borsey; P Leslie; R W Newton; C Lind; C B Ballinger
Journal:  Br J Psychiatry       Date:  1988-07       Impact factor: 9.319

View more
  9 in total

1.  Low Plasma Oxytocin Levels and Increased Psychopathology in Hypopituitary Men With Diabetes Insipidus.

Authors:  Anna Aulinas; Franziska Plessow; Elisa Asanza; Lisseth Silva; Dean A Marengi; WuQiang Fan; Parisa Abedi; Joseph Verbalis; Nicholas A Tritos; Lisa Nachtigall; Alexander T Faje; Karen K Miller; Elizabeth A Lawson
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  Acute psychosis as a presentation of hypopituitarism.

Authors:  Shruti Kate; Dinesh Kumar Dhanwal; Shishir Kumar; Praveen Bharti
Journal:  BMJ Case Rep       Date:  2013-07-13

3.  Risk of Mental Illnesses in Patients With Hypopituitarism: A Nationwide Population-Based Cohort Study.

Authors:  I-Hua Wei; Chih-Chia Huang
Journal:  Psychiatry Investig       Date:  2022-06-15       Impact factor: 3.202

Review 4.  Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.

Authors:  Xin He; Ariel L Barkan
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

Review 5.  [Growth hormone therapy in adults. Attempt to assess a decade of use].

Authors:  M Faust; C J Strasburger
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

6.  Sheehan's Syndrome Presenting as Major Depressive Disorder.

Authors:  Mehmood I Qadri; Mohsin Bin Mushtaq; Iram Qazi; Sameena Yousuf; Aaliya Rashid
Journal:  Iran J Med Sci       Date:  2015-01

7.  Chronic Atypical Depression as an Early Feature of Pituitary Adenoma: A Case Report and Literature Review.

Authors:  Filipa Cardoso; Heela Azizi; Alexander Kilpatrick; Olaniyi Olayinka; Tasmia Khan; Alexa Kahn; Cecilia Canale; Chiedozie Ojimba; Olusegun Popoola; Deepa Nuthalapati; Maleeha Ahmad; Mirna Iskander; Ali Chohan; Sara Parisi; Ulunma Umesi; Hashem Kalbouneh; Arka Bhattacharya; Kodjovi Kodjo; Oluwole Jegede; Ayodeji Jolayemi
Journal:  Case Rep Psychiatry       Date:  2019-07-21

8.  Impaired neuropsychological functioning in patients with hypopituitarism.

Authors:  Tessa N A Slagboom; Jan Berend Deijen; Christa C Van Bunderen; Hans A Knoop; Madeleine L Drent
Journal:  Endocrinol Diabetes Metab       Date:  2020-06-29

9.  Comorbidity of depression and anxiety: association with poor quality of life in type 1 and 2 diabetic patients.

Authors:  Ana Claudia C de Ornelas Maia; Arthur de Azevedo Braga; Flávia Paes; Sergio Machado; Mauro Giovanni Carta; Antonio Egidio Nardi; Adriana Cardoso Silva
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.